Ricin - Revision history

Mholtz at 06:19, 27 December 2016

2016-12-27T06:19:02Z

← Revisión anterior		Revisión del 06:19 27 dic 2016
Línea 24:		Línea 24:

	==Disposition==		==Disposition==
			*Admit

	==See Also==		==See Also==


	==External Links==		==External Links==


	==References==		==References==
	<references/>		<references/>
	*Lutwick LI,Gradon J, Zellen J: Category B Biotoxins. In Lutwick LI, Lutwick SM (eds), Beyond Anthrax: Bioterror - The Weaponization of Infectious Diseases. Springer-Humana, New York, 2009, New York, pp. 181-206:

	[[Category:Toxicology]]		[[Category:Toxicology]]
	[[Category:EMS]]		[[Category:EMS]]

2016-07-24T22:38:25Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Revisión anterior		Revisión del 22:38 24 jul 2016
Línea 16:		Línea 16:
	{{Bioterrorism agents}}		{{Bioterrorism agents}}

	==~~Diagnosis~~==		==Evaluation==
	*Chest x-ray = bilateral infiltrates ([[pulmonary edema]])		*Chest x-ray = bilateral infiltrates ([[pulmonary edema]])
	*Multi-organ failure occurred with a prominently elevated white blood cell count		*Multi-organ failure occurred with a prominently elevated white blood cell count

2016-03-22T16:23:05Z

Text replacement - "Category:Tox" to "Category:Toxicology"

← Revisión anterior		Revisión del 16:23 22 mar 2016
Línea 33:		Línea 33:
	*Lutwick LI,Gradon J, Zellen J: Category B Biotoxins. In Lutwick LI, Lutwick SM (eds), Beyond Anthrax: Bioterror - The Weaponization of Infectious Diseases. Springer-Humana, New York, 2009, New York, pp. 181-206:		*Lutwick LI,Gradon J, Zellen J: Category B Biotoxins. In Lutwick LI, Lutwick SM (eds), Beyond Anthrax: Bioterror - The Weaponization of Infectious Diseases. Springer-Humana, New York, 2009, New York, pp. 181-206:

	[[Category:~~Tox~~]]		[[Category:Toxicology]]
	[[Category:EMS]]		[[Category:EMS]]

2016-02-13T06:11:06Z

2015-06-10T02:08:07Z

Differential Diagnosis

2015-06-10T02:04:22Z

Differential Diagnosis

2015-06-10T02:03:42Z

← Revisión anterior		Revisión del 02:03 10 jun 2015
Línea 6:		Línea 6:
	==Clinical Features==		==Clinical Features==
	*First symptoms occur 3-12 hours after exposure		*First symptoms occur 3-12 hours after exposure
	*Multi-organ failure occurred with a prominently elevated white blood cell count
	*Acute lung injury		*Acute lung injury
	**~~Pulmonary edema may develop one to 3 days after exposure~~		**Fever, cough, shortness of breath, and nausea
	***fever, cough, shortness of breath, and nausea
	*Death 36-48 hours after exposure		*Death 36-48 hours after exposure
	**Alveolar flooding, fibropurulent pneumonia, and necrotizing tracheitis		**Alveolar flooding, fibropurulent pneumonia, and necrotizing tracheitis
Línea 16:		Línea 14:

	==Diagnosis==		==Diagnosis==
	*Chest x-ray = bilateral infiltrates		*Chest x-ray = bilateral infiltrates ([[pulmonary edema]])
			*Multi-organ failure occurred with a prominently elevated white blood cell count

	==Management==		==Management==

2015-06-10T02:02:37Z

Background

← Revisión anterior		Revisión del 02:02 10 jun 2015
Línea 2:		Línea 2:
	*Found in castor beans from the plant ''Ricinus communis''		*Found in castor beans from the plant ''Ricinus communis''
	**A residual product of the production of castor oil (if properly prepared, does not contain the toxin)		**A residual product of the production of castor oil (if properly prepared, does not contain the toxin)
			*Exposure can be parenteral, inhaled, or ingested

	==Clinical Features==		==Clinical Features==

2015-06-10T02:02:11Z

Clinical Features

← Revisión anterior		Revisión del 02:02 10 jun 2015
Línea 4:		Línea 4:

	==Clinical Features==		==Clinical Features==
	*Depends on type of exposure (parenteral, inhaled, or ingested)
	*First symptoms occur 3-12 hours after exposure		*First symptoms occur 3-12 hours after exposure
	*Multi-organ failure occurred with a prominently elevated white blood cell count		*Multi-organ failure occurred with a prominently elevated white blood cell count

2015-06-10T02:01:46Z

Clinical Features

← Revisión anterior		Revisión del 02:01 10 jun 2015
Línea 5:		Línea 5:
	==Clinical Features==		==Clinical Features==
	*Depends on type of exposure (parenteral, inhaled, or ingested)		*Depends on type of exposure (parenteral, inhaled, or ingested)
	*First symptoms ~~occcur~~ 3-12 hours after exposure		*First symptoms occur 3-12 hours after exposure
	*~~Multiorgan~~ failure occurred with a prominently elevated white blood cell count.		*Multi-organ failure occurred with a prominently elevated white blood cell count
	*~~acute~~ lung injury		*Acute lung injury
	*Pulmonary edema may develop one to 3 days after exposure,		**Pulmonary edema may develop one to 3 days after exposure
	**fever, cough, shortness of breath, and nausea.		***fever, cough, shortness of breath, and nausea
	*symptoms and time to death were also dose related and associated with alveolar flooding, fibropurulent pneumonia, and necrotizing tracheitis
	*Death 36-48 hours after exposure		*Death 36-48 hours after exposure
			**Alveolar flooding, fibropurulent pneumonia, and necrotizing tracheitis

	==Differential Diagnosis==		==Differential Diagnosis==